An individual is said to be suffering from invasive bladder cancer when the bladder cancer is at the T2 or T3 stage. Typically in T2 invasive bladder cancer the cancer cells would have spread from the lining of the inner walls of the bladder to the muscular layer of the bladder. On the other hand T3 invasive bladder cancer is when the cancer has grown through the muscle layer as well, increasing the risk of the cancer then spreading to other parts of the body.
Invasive bladder cancer symptoms are similar to those that are observed in bladder cancer that may be in the mid stages. These include:
In cases where in the invasive bladder cancer has spread to other parts of the body the individual may also experience weight loss, anemia, pain in the pelvic or rectal area as well as swelling or pain in the lower legs and around the kidneys.
Typically in case of invasive bladder cancer since the cancer has spread to the muscle layer of the bladder, the oncologist will recommend one of the below mentioned invasive bladder cancer treatment options:
Many a times while treating invasive bladder cancer, it has been observed that administering chemotherapy and radiotherapy at the same time helps. This treatment option is found to be more effective than radiation alone being given. This treatment for invasive bladder cancer is known as concurrent chemoradiation.
The prognosis for individuals diagnosed with bladder cancer depends on certain factors such as the individual's age and overall health status, stage at which the bladder cancer was diagnosed as well as the type of bladder cancer cells. Typically, superficial bladder cancer is known to have an 85% survival rate whereas the prognosis for invasive bladder cancer is not so favorable. Studies have shown that 5% of individuals diagnosed with invasive bladder cancer are known to survive for two years post diagnosis of the cancer. On the other hand the invasive bladder cancer survival rate in case of cancer that has recurred is an indication of a poor prognosis on account of the aggressive tumor in the area.
References